Ignite Creation Date:
2024-05-06 @ 9:30 AM
Last Modification Date:
2024-10-26 @ 12:15 PM
Study NCT ID:
NCT02999984
Status:
COMPLETED
Last Update Posted:
2022-08-03
First Post:
2016-12-19
Brief Title:
Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID
Sponsor:
University of California Los Angeles
Organization:
University of California Los Angeles
Organization Data
Organization:
University of California Los Angeles
Class:
OTHER
Study ID:
OTL-101-4
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of California Los Angeles
Lead Sponsor Class:
OTHER
Responsible Party:
Donald B Kohn MD
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of California Los Angeles
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Orchard Therapeutics | INDUSTRY |
| California Institute for Regenerative Medicine CIRM | OTHER |